HRID 52177生成物として
154355-75-6C[C@H](C#Cc1ccc(Cc2ccc(F)cc2)s1)N(O)C(N)=OMMSNEKOTSJRTRI-LLVKDONJSA-NAtreleuton has been used in trials studying the treatment of Atherosclerosis and Coronary Artery Disease.
154355-75-6、154355-76-7DTXSID10165598CHEMBL59356安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 38 reports by companies from 1 notifications to the ECHA C&L Inventory.
使用Anti-asthmatic; inhibitor (5-lipoxygenase).